Sign In
Buy CGEN
$2.34
-0.0700 (-2.90%)
At Close: Aug 10, 2026
Compugen Announces Pricing of $75 Million Public Offering of Ordinary Shares
10:05am, Thursday, 12'th Mar 2020
Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the pricing of an underwritten public offering of 8,333,334 ord
Mid-Afternoon Market Update: Dow Tumbles Over 2000 Points; Inovio Pharmaceuticals Shares Gain
12:00am, Thursday, 12'th Mar 2020108 Biggest Movers From Yesterday
09:34am, Wednesday, 11'th Mar 2020
Gainers
Cypress Semiconductor Corporation (NASDAQ: CY) shares jumped 48.9% to close at $22.75 on Tuesday after the company received clearance from the Committee on Foreign...
82 Stocks Moving In Tuesday's Mid-Day Session
04:25pm, Tuesday, 10'th Mar 2020
Gainers
Cypress Semiconductor Corporation (NASDAQ: CY) climbed 45.8% to $22.28 after the company received clearance from the Committee on Foreign Investment in the United States...
Stocks That Hit 52-Week Highs On Tuesday
02:19pm, Tuesday, 10'th Mar 2020
During Tuesday's morning trading, 12 companies set new 52-week highs.
Areas of Significance:
The largest company by market cap to break to a new 52-week high was Dollar...
Company News for Mar 10, 2020
02:00pm, Tuesday, 10'th Mar 2020
Companies In The News Are: COCP, CGEN, AAPL, NINE
101 Stocks Moving In Monday's Mid-Day Session
04:00pm, Monday, 09'th Mar 2020
Gainers
Spherix Incorporated (NASDAQ: SPEX) shares jumped 139% to $3.92 after jumping 131% on Friday.
AIM ImmunoTech Inc. (NYSE: AIM) shares jumped 63.1% to $3.43 amid the...
Reviewing Compugen (NASDAQ:CGEN) and Repligen (NASDAQ:RGEN)
06:10am, Saturday, 07'th Mar 2020
Compugen (NASDAQ:CGEN) and Repligen (NASDAQ:RGEN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership,
Compugen: TIGIT Is The New Black
06:03pm, Monday, 02'nd Mar 2020
The anti-TIGIT approach is considered to be a promising anti-cancer strategy. Compugen is developing COM902, its own anti-TIGIT antibody. Bristol-Myers Squi
Investing in a Genomic Revolution
10:00am, Friday, 28'th Feb 2020
The increasing ability of human beings to treat formerly lethal diseases has had a massive effect on the quality of our lives over the past century, explains Jim Woods, editor of The Deep Woods.
